Irish medical and pharmaceutical exports to the US have seen a significant surge, with a year-on-year increase above 450% in February 2025, according to data released on 15 April and reported by Reuters.

The spike in exports comes as the drug manufacturers in the US stockpile medicines in anticipation of new tariffs.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Ireland’s Central Statistics Office stated that in February, these product exports to the US reached €10.5bn ($11.8bn), up from €1.9bn in the same month of 2024.

This follows a substantial increase in January, when exports rose 130% to €9.4bn.

The US administration has initiated an investigation into pharmaceutical imports, with President Donald Trump expressing his intention to impose tariffs on these goods shortly.

Trump has specifically targeted the manufacture of drugs in Europe, with a focus on Ireland, as an area for potential tariffs.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Ireland hosts 12 of the largest global drug manufacturers, many of which produce medicines or active ingredients for the American market.

The recent export increases have been attributed by Ireland’s Central Bank to the production of in-demand weight-loss drugs, but also suggest stockpiling activities due to tariff threats.

In response to these threats, a few manufacturers have resorted to air-freighting more medicines to the US, as indicated by two executives and two logistics firms to Reuters.

In February 2025, President Trump signed a memorandum directing his staff to develop country-specific tariffs, considering factors such as currency values, current tariff rates and trade balances.

The move heightened the sense of urgency among pharmaceutical companies to secure their US supply chains.

The BBC reports state that the Republic of Ireland’s export of goods to the US increased by more than 200% in February 2025.

Trump has also hinted that the US is set to announce major tariffs on pharmaceutical imports soon.

Navigate the shifting tariff landscape with real-time data and market-leading analysis.

Request a free demo for GlobalData’s Strategic Intelligence here.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact